Ferroptosis and Ferroptotic Stress in Maladaptive Renal Repair

适应不良肾修复中的铁死亡和铁死亡应激

基本信息

  • 批准号:
    10655821
  • 负责人:
  • 金额:
    $ 52.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-15 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Acute kidney injury (AKI) is a major health problem, afflicting 1.2 million hospitalized patients annually in the US. Maladaptive renal repair after AKI promotes development of chronic kidney disease (CKD), leaving affected patients at high risk for dialysis dependency, cardiovascular events, and mortality. Studies show that males are disproportionately and more severely affected by AKI than females, including COVID-19-associated AKI. However, the molecular mechanisms underlying this sexual dimorphism remain poorly understood. Moreover, there are no targeted therapies that interrupt this devastating disease process in both sexes. Using single-cell transcriptomics and mouse genetics, our ongoing studies found that the female sex confers marked protection against ferroptosis, a distinct, non-apoptotic form of regulated cell death and a critical driver of maladaptive repair after AKI in mice and humans. Ferroptosis is triggered by the inability of glutathione peroxidase 4 (GPX4) to remove toxic lipid peroxides from cell membranes, leading to the accelerated accumulation of toxic lipid peroxides (ferroptotic stress) and cell rupture. Acute ischemic and toxic kidney injuries reduce GPX4 in proximal tubular (PT) cells, thus making these cells vulnerable to ferroptosis. Severe AKI also induces pathologic transcriptional alteration of PT cells into an inflammatory phenotype and prevents their recovery to a healthy state (impaired plasticity). Our data show that in males but not in females, genetic deletion of Gpx4 promotes the accumulation of inflammatory PT cells and triggers their death by ferroptosis. To advance these clinically impactful lines of investigation, we will test our overarching hypothesis that sexual dimorphism in resilience to ferroptosis underlies sex differences in clinical outcomes after AKI. We further hypothesize that uncovering the mechanisms of how sex hormones regulate ferroptosis sensitivity will enable identification of targetable downstream pathways that improve AKI outcomes for both sexes. Directly testing these hypotheses, we will integrate unbiased single-cell transcriptomics, genetic mouse models, pharmacological studies, and human kidney organoids with two Specific Aims. In Aim 1, we will determine sex-dependent mechanisms by which ferroptosis promotes maladaptive repair at single-cell resolution using our tubule-specific, doxycycline-inducible Gpx4 knockout mouse model. We will also investigate the therapeutic effects of ferroptosis inhibitors to enhance renal repair in our murine kidney injury models in vivo and in human in vitro AKI models using organoids. In Aim 2, we will test our hypothesis that sex hormones regulate the sensitivity to ferroptosis and PT cell plasticity after AKI using gonadectomy and genetic inhibition of estrogen receptor signaling. The results of these studies will provide compelling preclinical mechanistic evidence for how ferroptotic stress governs PT cell fate. Our studies will identify new therapeutic targets to enhance renal ferroptotic stress resilience and promote healthy PT recovery from injury, thereby interrupting the AKI to CKD transition in both sexes.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tomokazu Souma其他文献

Tomokazu Souma的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tomokazu Souma', 18)}}的其他基金

Targeting Renal Tubular Epithelial Progenitors in AKI to CKD transition
在 AKI 向 CKD 转变过程中靶向肾小管上皮祖细胞
  • 批准号:
    10180959
  • 财政年份:
    2020
  • 资助金额:
    $ 52.38万
  • 项目类别:
Targeting Renal Tubular Epithelial Progenitors in AKI to CKD transition
在 AKI 向 CKD 转变过程中靶向肾小管上皮祖细胞
  • 批准号:
    10431892
  • 财政年份:
    2020
  • 资助金额:
    $ 52.38万
  • 项目类别:
Targeting Renal Tubular Epithelial Progenitors in AKI to CKD transition
在 AKI 向 CKD 转变过程中靶向肾小管上皮祖细胞
  • 批准号:
    10655482
  • 财政年份:
    2020
  • 资助金额:
    $ 52.38万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 52.38万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了